期刊
NANOTECHNOLOGY
卷 26, 期 20, 页码 -出版社
IOP PUBLISHING LTD
DOI: 10.1088/0957-4484/26/20/205101
关键词
nanoparticles; oral exposure; biotransformation; bioavailability; iron absorption; iron oxide
资金
- European Commission (MULTIFUN) [262943]
- Madrid Regional Government NANOFRONTMAG-CM [S2013/MIT-2850]
- Spanish Ministry of Economy and Competitiveness [MAT2010-21822-C02-01, MAT2013-47395-C4-3-R]
- Ramon y Cajal subprogram [RYC-2011-09617]
- AXA Research Fund
Iron oxide nanoparticles with engineered physical and biochemical properties are finding a rapidly increasing number of biomedical applications. However, a wide variety of safety concerns, especially those related to oral exposure, still need to be addressed for iron oxide nanoparticles in order to reach clinical practice. Here, we report on the effects of chronic oral exposure to low doses of gamma-Fe2O3 nanoparticles in growing chickens. Animal observation, weight, and diet intake reveal no adverse signs, symptoms, or mortality. No nanoparticle accumulation was observed in liver, spleen, and duodenum, with feces as the main excretion route. Liver iron level and duodenal villi morphology reflect the bioavailability of the iron released from the partial transformation of gamma-Fe2O3 nanoparticles in the acid gastric environment. Duodenal gene expression studies related to the absorption of iron from gamma-Fe2O3 nanoparticles indicate the enhancement of a ferric over ferrous pathway supporting the role of mucins. Our findings reveal that oral administration of iron oxide nanoparticles is a safe route for drug delivery at low nanoparticle doses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据